Spada Alfred P. 4
4 · Histogen Inc. · Filed May 27, 2020
Insider Transaction Report
Form 4
Histogen Inc.HSTO
Spada Alfred P.
SVP, R&D and CSO
Transactions
- Exercise/Conversion
Common Stock
2020-05-22+31,343→ 32,555 total - Tax Payment
Common Stock
2020-05-22$0.56/sh−12,960$7,258→ 19,595 total - Exercise/Conversion
Restricted Stock Units
2020-05-22−31,343→ 0 total→ Common Stock (31,343 underlying)
Holdings
- 24,714(indirect: See footnote)
Common Stock
Footnotes (3)
- [F1]Held by a family trust of which Dr. Spada is a trustee.
- [F2]Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock.
- [F3]Pursuant to the Agreement and Plan of Merger and Reorganization (the "Merger Agreement") by and among Conatus Pharmaceuticals Inc. ("Conatus"), Chinook Merger Sub, Inc. and Histogen Inc., all outstanding Conatus restricted stock units vested in full and were settled in shares of common stock prior to the closing of the merger contemplated by the Merger Agreement.